MetaCap

Park Ha Biological Technology Co. Ltd. Class A (BYAH)

NASDAQ: BYAHConsumer DiscretionaryPackage Goods/CosmeticsUSD

0.8501-0.1899 (-18.26%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

BYAH stock chart

Technical analysis

Key statistics

All statistics
Market cap
$16.59M
EPS (TTM)
-$37.68
52-week range
0.85 – 112.00
Day range
0.85 – 1.12
Volume / Avg
55.16K / 193.24K
Beta
—

52-week range

$0.85$112.00

BYAH stock today

Shares of Park Ha Biological Technology (BYAH) finished lower on Nov 20 at $0.8501, a drop of 18.26% or $0.1899 per share, versus the S&P 500's 3.70% decline. Trading was light, with 55.16K shares changing hands, about 29% of the average daily volume. At this level, BYAH sits near the bottom of its 52-week range of $0.85 to $112.00: 99.2% below the high and 0.0% above the low.

Park Ha Biological Technology has posted a net loss over the last twelve months (EPS of -$37.68), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Park Ha Biological Technology

Company profile

Park Ha Biological Technology Co., Ltd., investment holding company, develops skincare products in the People's Republic of China. It operates in two segments, Product Sales and Franchise Service. The company offers various products, such as basic skin physical protection, exfoliation, and sebum film repair to surface microecological balance, and anti-aging under the Park Ha brand.

Industry
Package Goods/Cosmetics
CEO
Ms. Xiaoqiu Zhang
Headquarters
Wuxi
Employees
41
IPO year
2024
Website
parkha.cn

Financial highlights

Full financials

In fiscal 2025, Park Ha Biological Technology generated $2.5 million in revenue, up 6.0% from fiscal 2024. Park Ha Biological Technology reported a net loss of $24.4 million, compared with net income of $478,561 a year earlier. Gross margin was 94.4% (up from 91.8%) and operating margin -956.5%.

Park Ha Biological Technology annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022
Revenue$2.52M$2.38M$2.46M$1.92M
Growth+6.00%-3.14%+28.12%—
Net income$-24.36M$478.56K$852.04K$191.30K
EPS (diluted)$-41.38$0.96$1.70$0.01

Park Ha Biological Technology peers

Consumer Discretionary sector
BYAH peer companies
CompanyPrice% ChgMarket capCompare
CABRCaring Brands Inc.0.660.00%$7.59Mvs BYAH
YCBDcbdMD Inc.0.36-5.11%$4.84Mvs BYAH
BIOTInstinct Bio Technical Company Holdings Inc.0.1432-12.15%$4.12Mvs BYAH
AXILAXIL Brands Inc.4.27-5.22%$29.13Mvs BYAH
BNKKBonk Inc.0.4558-3.41%$3.91Mvs BYAH
UGUnited-Guardian Inc.7.35+4.11%$33.77Mvs BYAH
WNWMeiwu Technology Company Limited1.65-13.42%$43.31Mvs BYAH
SLSNSolesence Inc.1.41-4.73%$99.61Mvs BYAH

Indexes, lists and sector

Park Ha Biological Technology stock FAQ

What is Park Ha Biological Technology's stock price today?

BYAH last traded at $0.8501 as of Nov 20, 4:00 PM EST, down 18.26% on the day. Prices are delayed at least 15 minutes.

Who is Park Ha Biological Technology's CEO?

Ms. Xiaoqiu Zhang is the chief executive officer of Park Ha Biological Technology Co. Ltd. Class A, which has about 41 employees.

What is the BYAH 52-week high?

The 52-week high for BYAH is $112.00 and the 52-week low is $0.85. The stock is currently 99.2% below its high.

Compare BYAH